Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/64745
Title: Enhancing cognition before clinical symptoms of dementia.
Author: Franco Fernández, Rafael
Keywords: Malaltia d'Alzheimer
Genètica humana
Vitamina C
Inhibidors de fosfodiesterases
Alzheimer's disease
Human genetics
Vitamin C
Phosphodiesterase Inhibitors
Issue Date: 16-Dec-2014
Publisher: Frontiers
Abstract: As the title of the special issue indicates, controversy surrounds augmentation of brain cognition in humans. Lacking efficacious drugs for Alzheimer's disease (AD) and with many AD patients recruited for clinical trials that unfortunately do not provide the expected results, one wonders whether to test cognition enhancement strategies in individuals without symptoms of cognition decline. This opinion article presents the view that safe drugs and or dietary supplements should be tested worldwide in aged individuals under the control of a non-for-profit organization.
Note: Reproducció del document publicat a: http://dx.doi.org/10.3389/fnsys.2014.00240
It is part of: Frontiers in systems Neuroscience, 2014, vol. 8, p. 1-3
Related resource: http://dx.doi.org/10.3389/fnsys.2014.00240
URI: http://hdl.handle.net/2445/64745
ISSN: 1662-5137
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
649521.pdf590.16 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons